According to Tandem Diabetes Care 's latest financial reports the company's current revenue (TTM) is $0.74 B. In 2022 the company made a revenue of $0.80 B an increase over the years 2021 revenue that were of $0.70 B.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | $0.74 B | -6.68% |
2022 | $0.80 B | 14% |
2021 | $0.70 B | 40.89% |
2020 | $0.49 B | 37.68% |
2019 | $0.36 B | 97.05% |
2018 | $0.18 B | 70.88% |
2017 | $0.10 B | 27.72% |
2016 | $84.24 M | 15.65% |
2015 | $72.85 M | 46.51% |
2014 | $49.72 M | 71.42% |
2013 | $29 M |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Johnson & Johnson JNJ | $93.02 B | 12,340.79% | ๐บ๐ธ USA |
Medtronic MDT | $32.32 B | 4,222.49% | ๐ฎ๐ช Ireland |
ICU Medical
ICUI | $2.25 B | 202.14% | ๐บ๐ธ USA |
DexCom DXCM | $3.80 B | 408.45% | ๐บ๐ธ USA |
Insulet PODD | $1.69 B | 126.97% | ๐บ๐ธ USA |